Rob Hart

Rob Hart is a Partner at Telegraph Hill Partners based in Miami, Florida, where he manages venture capital and growth equity investments across the life sciences and healthcare technology sectors. Since 1998, he has developed expertise in corporate finance and securities law through previous roles at Citigroup Global Markets, the Securities and Exchange Commission, and Cravath, Swaine and Moore. At Telegraph Hill Partners, Hart recently participated in closing the firm's $525 million fifth fund and led a strategic minority investment in Promptly Technology. His portfolio involvement includes board and observer roles at Akoya Biosciences and Nimble Therapeutics, prior to its acquisition by AbbVie. Holding a JD and MBA from Northwestern University alongside a CFA designation, Hart focuses on guiding healthcare and medical device companies from their early startup stages through full commercial scale.